StockData
BDMDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as BDMDW

Baird Medical Investment Holdings Ltd

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 24, 2026
$0.44−0.13 (-22.97%)

Close on Oct 19, 2026

Market cap
–
P/E (TTM)
–
Dividend yield
–

Baird Medical Investment statistics

Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Surgical & Medical Instruments & Apparatus companies for comparison

Valuation

MeasureBaird Medical InvestmentIndustry median
Market Cap$17.87M$230.55M
Enterprise Value$25.17M$202.97M
PS Ratio0.793.10
PB Ratio0.513.04
P/TBV Ratio0.514.43

Enterprise value

MeasureBaird Medical InvestmentIndustry median
EV / Sales1.122.91

Income (trailing twelve months)

MeasureBaird Medical InvestmentIndustry median
Revenue$22.54M$102.39M
Gross Profit$18.88M$60.36M
Operating Income-$25.63M-$4.31M
Pretax Income-$26.38M-$2.37M
Net Income-$27.28M-$6.57M
EBITDA-$24.53M-$1.98M
EPS (Diluted)-$0.98-$0.08

Margins

MeasureBaird Medical InvestmentIndustry median
Gross Margin83.8%55.2%
Operating Margin-113.7%-6.04%
Pretax Margin-117.0%-4.11%
Profit Margin-121.0%-10.5%
EBITDA Margin-108.8%-2.67%
FCF Margin-6.15%0.02%

Returns

MeasureBaird Medical InvestmentIndustry median
Return on Equity (ROE)-77.5%-18.2%
Return on Assets (ROA)-36.2%-13.3%
Return on Invested Capital (ROIC)-48.2%-3.69%
Return on Capital Employed (ROCE)-65.8%-9.07%

Growth

MeasureBaird Medical InvestmentIndustry median
Revenue Growth (YoY)-39.2%8.85%
Net Income Growth (YoY)-319.0%10.5%
EPS Growth (YoY)-271.9%10.6%
Revenue Growth (3Y CAGR)-13.7%7.08%

Balance sheet

MeasureBaird Medical InvestmentIndustry median
Cash & Short-Term Investments$138.55K$36.66M
Total Debt$7.60M$97.65M
Net Cash (Debt)-$7.46M$3.92M
Net Cash Per Share-$0.18$0.28
Equity (Book Value)$34.78M$55.33M
Book Value Per Share$0.85$2.87
Tangible Book Value$34.71M$10.79M
Working Capital$10.18M$56.72M

Financial position

MeasureBaird Medical InvestmentIndustry median
Current Ratio1.292.48
Quick Ratio0.881.53
Debt / Equity0.220.41
Interest Coverage-72.33-1.85

Cash flow (trailing twelve months)

MeasureBaird Medical InvestmentIndustry median
Operating Cash Flow-$1.34M-$566.22K
Capital Expenditures-$42.32K-$3.69M
Free Cash Flow-$1.39M-$696.00K
FCF Per Share-$0.03-$0.02

Efficiency

MeasureBaird Medical InvestmentIndustry median
Asset Turnover0.300.58
Inventory Turnover2.972.21
Revenue Per Employee$154.36K$322.92K
Profits Per Employee-$186.84K-$51.88K
Employee Count146185

Dividends and yields

MeasureBaird Medical InvestmentIndustry median
Earnings Yield-152.7%-6.88%
FCF Yield-7.76%-0.45%

Shares

MeasureBaird Medical InvestmentIndustry median
Shares Outstanding40,979,40044,302,700
Shares Change (YoY)27.3%3.36%
Float15,586,40037,462,700
Shares Held by Insiders62.0%10.5%

Taxes

MeasureBaird Medical InvestmentIndustry median
Income Tax$1.17M$1.52M

Scores

MeasureBaird Medical InvestmentIndustry median
Altman Z-Score-0.411.95
Piotroski F-Score15
Beneish M-Score-4.60-2.64

Calculated by StockData from Baird Medical Investment's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.